201 A Re-audit of Lignocaine 5% Medicated Plaster (Versatis ®) Prescribing in an Older Adult Inpatient Population Following Changes to Reimbursement Provisions

ConclusionNo patient was newly prescribed Versatis ® during their admission. The MMP directive for the prescribing of Versatis® influenced prescribing practice across our hospital sites. Community practice for prescribing off-label is still evident for chronic pain, reflecting the difficulty of pain control in older adults. The cost of individual plasters increased by 0.88€ since 2017.
Source: Age and Ageing - Category: Geriatrics Source Type: research